Navigation Links
Zyga Technology, Inc. Announces the Appointment of Jim Bullock as President and CEO
Date:1/16/2012

MINNEAPOLIS, Jan. 16, 2012 /PRNewswire/ -- Zyga Technology, Inc. announced today that Jim Bullock has been named as the new President and CEO of the company.  Before joining Zyga Technology, Jim was President and CEO of Atritech, Inc. which was recently sold to Boston Scientific.  Prior to Atritech, Jim was President and CEO of Endocardial Solutions, Inc., which was acquired by St. Jude Medical. 

(Logo: http://photos.prnewswire.com/prnh/20110118/CG30384LOGO)

"I am extremely excited about the opportunities here at Zyga.  In today's environment, success is determined by products that are clinically validated to address the unmet needs of clinicians, and we are committed to meeting that challenge. We are excited about the traction we are gaining in the market with the SImmetry™ Sacroiliac Joint Fusion System, and the early clinical study results from the GLYDER™ Facet Resurfacing System. " said Jim Bullock

According to Dave Stassen, Chairman of the Board of Zyga Technology, Inc., and managing director of Split Rock Partners, "We are very pleased that Jim has joined the team at Zyga.  Jim has a phenomenal track record of creating value for start-up companies in the medical device industry.  Jim has been involved in medical devices throughout his career and brings a great deal of energy, commercialization success and strategic experience to Zyga."

Sacroiliac joint dysfunction and facetogenic pain have been shown to be the source of pain for up to 20% & 30% of patients suffering from low back pain respectively. Patients who suffer from these conditions typically receive therapeutic injections which temporarily address the problem but require long-term repeat treatments.  Traditional, open surgery has been performed to address these conditions but is limited in practice due to its complexity, high complication rate and generally poor outcomes.

About Zyga Technology, Inc.

Based in Minneapolis, MN, Zyga Technology, Inc. was founded to develop and market innovative, minimally invasive surgical solutions to treat conditions of the spine.  Zyga has put together a team of engineers, marketing personnel, and management with significant experience developing medical devices for the spine industry.


'/>"/>
SOURCE Zyga Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
2. eResearchTechnology, Inc. to Present at the Thomas Weisel Healthcare Conference on September 4th, 2008
3. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
4. eResearchTechnology, Inc. to Present at the UBS Global Life Sciences Conference on September 23rd, 2008
5. eResearchTechnology, Inc. to Announce 2008 Third Quarter Results on October 30, 2008
6. TechConnect World 2009 Matches Tomorrows Technology Solutions with Todays Business Needs for Clean-Technology, Biotechnology and Nanotechnology
7. eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008
8. ERT (eResearchTechnology, Inc.) and Integrium, LLC Form Alliance to Deliver Integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring Services
9. Multisol France on Track to Sell 250 Tons of International Fuel Technology, Inc. Fuel Additive Formulations
10. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
11. Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 18, 2017 , ... The ... (NIH) to update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, ... subject to the existing policy. AMIA recommended that NIH earmark funding for researchers ...
(Date:1/19/2017)... 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), ... for operable and inoperable solid tumor cancers, announced today ... of NW Bio, will present at the Phacilitate Immunotherapy ... Hyatt Regency Hotel in Miami, Florida ... entitled "New Therapeutic Approaches – Expanding the Reach of ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017   Boston ... novel compounds designed to target cancer stemness pathways, will ... investigational compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers ... Francisco . Napabucasin is an ... by targeting STAT3. i Cancer stem cells (CSCs) ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse Labs has furthered ... Molecular Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables & ... further growth in 2017. Extractable & Leachable evaluations have become increasingly more vital ...
Breaking Biology Technology:
(Date:1/11/2017)... 2017  Michael Johnson, co-founder of Visikol Inc. a company originally ... been named to the elite "Forbes 30 Under 30" list in ... people in 20 fields nationwide to be recognized as a leader ... were selected. ... is currently a PhD candidate at Rutgers University. ...
(Date:1/4/2017)... Jan. 4, 2017  For the thousands of attendees at this year,s ... in connected health and biometric measurement devices and services, will be featuring ... On display in A&D Medical,s special CES Exhibit Suite , the ... expansion of the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... 2016 SuperCom (NASDAQ:   ... the e-Government, Public Safety, HealthCare, and Finance sectors announced today that ... selected to implement and deploy a community-based supportive services program to ... , further expanding its presence in the state. ... This new program, which is ...
Breaking Biology News(10 mins):